Your browser doesn't support javascript.
loading
Increased core body temperature exacerbates defective protein prenylation in mouse models of mevalonate kinase deficiency.
Munoz, Marcia A; Skinner, Oliver P; Masle-Farquhar, Etienne; Jurczyluk, Julie; Xiao, Ya; Fletcher, Emma K; Kristianto, Esther; Hodson, Mark P; O'Donoghue, Seán I; Kaur, Sandeep; Brink, Robert; Zahra, David G; Deenick, Elissa K; Perry, Kristen A; Robertson, Avril Ab; Mehr, Sam; Hissaria, Pravin; Mulders-Manders, Catharina M; Simon, Anna; Rogers, Michael J.
Affiliation
  • Munoz MA; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Skinner OP; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Masle-Farquhar E; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Jurczyluk J; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Xiao Y; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Fletcher EK; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Kristianto E; Victor Chang Cardiac Innovation Centre, Victor Chang Cardiac Research Institute, Sydney, New South Wales, Australia.
  • Hodson MP; School of Pharmacy, University of Queensland, Woolloongabba, Queensland, Australia.
  • O'Donoghue SI; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Kaur S; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Brink R; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Zahra DG; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Deenick EK; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Perry KA; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
  • Robertson AA; School of Chemistry and Molecular Biosciences, University of Queensland, Brisbane, Queensland, Australia.
  • Mehr S; Royal Children's Hospital, Melbourne, Victoria, Australia.
  • Hissaria P; Royal Adelaide Hospital, SA Pathology and University of Adelaide, Adelaide, South Australia, Australia.
  • Mulders-Manders CM; Department of Internal Medicine, Radboudumc Expertise Centre for Immunodeficiency and Autoinflammation, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Simon A; Department of Internal Medicine, Radboudumc Expertise Centre for Immunodeficiency and Autoinflammation, Radboud University Medical Centre, Nijmegen, Netherlands.
  • Rogers MJ; Garvan Institute of Medical Research and School of Clinical Medicine, UNSW Sydney, Sydney, New South Wales, Australia.
J Clin Invest ; 132(19)2022 10 03.
Article in En | MEDLINE | ID: mdl-36189795
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mevalonate Kinase Deficiency Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mevalonate Kinase Deficiency Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: J Clin Invest Year: 2022 Document type: Article Affiliation country: Country of publication: